RxDoctor Payments Data
★ My doctorsLook up a doctor →

Turgut Berkmen, MD

Vascular & Interventional Radiology · New Haven, CTNPI 1346232683

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 114 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Stryker at 39.0% of the total.

$6,666in general payments, 2019–2025

Across 114 payments — averaging $58.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Terumo Medical Corporation$973
  • Boston Scientific$959
  • Penumbra, Inc.$732
  • Balt USA, LLC$470
  • Inari Medical, Inc.$310
  • plus $623 from 10 others

What the payments were for

  • Food & beverage$6,666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker34$2,599
Terumo Medical Corporation20$973
Boston Scientific22$959
Penumbra, Inc.11$732
Balt USA, LLC5$470
Inari Medical, Inc.2$310
Cordis US CORP.1$136
Medtronic(3 entities)6$123
Bolton Medical Inc1$95
Imperative Care, Inc4$94
Johnson & Johnson(2 entities)2$51
Siemens Medical Solutions USA, Inc.2$48
Bard Peripheral Vascular, Inc.1$24
Cook Medical LLC1$18
GE HealthCare1$17
Covidien LP1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,666 in reported general payments places this provider in the 65th percentile of 50 vascular & interventional radiology providers in Connecticut.

See all vascular & interventional radiology providers in Connecticut →

Medicare billing

Part B allowed, 2024
$695,022
Medicare patients
402
Services billed
1,582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate21$272
Alprazolam225$139
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen44$34
Prednisone14$9

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in New Haven

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →